![Paul van Midwoud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Paul van Midwoud is associated with InGell Labs BV as a Lab Director & Manager-Pharmaceutical Projects since 2010.
He is also the founder of InGell Labs BV, which was founded in 2010.
Actieve functies van Paul van Midwoud
Bedrijven | Functie | Begin |
---|---|---|
InGell Labs BV
![]() InGell Labs BV Pharmaceuticals: MajorHealth Technology InGell Labs BV develops polymer-based injectable hydrogels for drug delivery. The firm’s products include InGell LQP, Ingell Gamma, and running in-house projects. It offers its bioabsorbable injectable hydrogel systems for reducing side-effects and localization of novel therapies to life-cycle management opportunities. The company was founded by Paul van Midwoud, Theodorus Adrianus Cornelius Flipsen, Mike G. de Leeuw, and Jan P. M. Hendriks in 2010 and is headquartered in Groningen, the Netherlands. | Oprichter | 01-01-2010 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
InGell Labs BV
![]() InGell Labs BV Pharmaceuticals: MajorHealth Technology InGell Labs BV develops polymer-based injectable hydrogels for drug delivery. The firm’s products include InGell LQP, Ingell Gamma, and running in-house projects. It offers its bioabsorbable injectable hydrogel systems for reducing side-effects and localization of novel therapies to life-cycle management opportunities. The company was founded by Paul van Midwoud, Theodorus Adrianus Cornelius Flipsen, Mike G. de Leeuw, and Jan P. M. Hendriks in 2010 and is headquartered in Groningen, the Netherlands. | Health Technology |